Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada

OBJECTIVE: To assess outcomes over 24 months in Canadian patients with schizophrenia initiated on risperidone long-acting injection (RLAI) and participating in the electronic Schizophrenia Treatment Adherence Registry (e-STAR). MATERIALS AND METHODS: Patients with schizophrenia or schizoaffective di...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Williams, Richard, Chandrasena, Ranjith, Beauclair, Linda, Luong, Doanh, Lam, Annette
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2014
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3942298/
https://ncbi.nlm.nih.gov/pubmed/24600227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S54740
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge